Measurement of ligand/anti-ligand interactions using bulk conductance

• US 4,713,347 A
• Filed: 01/14/1985
• Issued: 12/15/1987
• Est. Priority Date: 01/14/1985
• Status: Expired due to Fees

• Current Assignee: Sensor Diagnostics Incorporated
• Original Assignee: Sensor Diagnostics Incorporated
• Inventors: Mitchell, David H., Mitchell, Ralph M.
• Primary Examiner(s): Kepplinger, Esther M.
• Assistant Examiner(s): Jay, Jeremy M.
• Application Number:
  US06/691,271
• Time in Patent Office: 1,065 Days
• Field of Search: 204/403, 324/439, 324/61 P, 422/68, 422/69, 435/173, 435/291, 435/311, 435/807, 435/6, 436/149, 436/150, 436/501, 436/536, 436/806, 436/807, 436/829, 436/530, 436/533
• US Class Current: 436/501
• CPC Class Codes: G01N 33/5302 Apparatus specially adapted for immunological test procedures
• CPC Class Codes: G01N 33/5438 Electrodes
• CPC Class Codes: Y10S 436/806 Electrical property or magnetic property
• CPC Class Codes: Y10S 436/807 Apparatus included in process claim, e.g. physical support structures

Abstract

Methods, apparatus and sensors are described for detection of specific ligands in a fluid sample by measuring ligand-specific changes in the bulk electrical conductance (or resistance) of a fixed test volume, with antiligand or ligand localized in or near that volume.

Claims

1. A method for determining the presence of a ligand in a fluid sample comprising:

(a) localizing antiligand which interacts with said ligand in at least one predetermined region, said predetermined region being at least partially contained within a test volume;

(b) exposing said predetermined region to said fluid sample; and

(c) measuring the bulk conductance of said test volume to determine the occurrence of ligand-antiligand interaction in said predetermined region by detecting changes in the bulk conductance of said test volume due to ligand-antiligand interaction in said predetermined region.

2. The method of claim 1, wherein said localization of said antiligand in said predetermined region comprises confining said antiligand within the boundaries of a membrane, said membrane being permeable at least to said ligand.

3. The method of claim 1, wherein said ligand is selected from the group consisting of antigens, cell surface antigens, antigenic determinants, haptens, antibodies, antibody fragments, monovalent antibody fragments, nucleic acid sequences, enzymes, cofactors, enzyme substrates, genetically or chemically altered proteins, receptor protein, permeases, other transport proteins, binding proteins, molecules bound by a permease, transport protein or binding protein, carbohydrates, lectins, metal ions, metal-binding proteins, and other metal-binding substances.

4. The method of claim 1, wherein said antiligand has high affinity for said ligand.

5. The method of claim 1, wherein said antiligand has low affinity for said ligand.

6. The method of claim 1, including the step of forming a complex between an antiligand specific for said ligand to be determined and an amplifying substance.

7. The method of claim 6, wherein said complex is preformed and said ligand in said fluid sample binds to said antiligand component of said complex and further binds to said antiligand in said predetermined region.

8. The method of claim 1, wherein the bulk conductance of said test volume is measured with electrodes which are in contact with an electrolyte.

9. The method of claim 8, wherein four electrodes are used to measure the bulk conductance of said test volume, two of said electrodes providing a current through said test volume whose bulk conductance is being measured and two of said electrodes measuring the voltage drop across said test volume.

10. The method of claim 9, wherein said voltage electrodes are recessed from said current.

11. The method of claim 9, wherein said current electrodes are recessed from said test volume.

12. The method of claim 1, wherein said localization of said antiligand in said predetermined region comprises immobilizing said antiligand on a matrix.

13. The method of claim 12, wherein said matrix is selected from the group consisting of gel beads, gel layers, glass beads, polymeric beads, microporous membranes, porous paper, and mixtures thereof.

14. The method of claim 12, wherein said matrix is contacted with a flowing stream of said fluid sample.

15. The method of claim 14, wherein said contacting comprises causing said fluid sample to flow through said matrix.

16. The method of claim 14, wherein said contacting comprises causing said fluid sample to flow past said matrix.

17. The method of claim 1, wherein said changes in bulk conductance are determined by comparing the bulk conductance of said test volume with the bulk conductance of at least one control volume.

18. The method of claim 17, wherein said control volume does not contain any localized substance therein.

19. The method of claim 17, wherein said fluid sample contains a known concentration of a control ligand, and control antiligand which interacts with said control ligand is localized in at least one predetermined region of said control volume.

20. The method of claim 17, wherein said control volume does not contain antiligand which reacts with said ligand.

21. The method of claim 20, wherein said control volume is substantially free of specific interactions which effect changes in bulk conductance.

22. The method of claim 21, said control volume at least partially containing therein at least one predetermined region, said predetermined region being exposed to said fluid sample and also having localized therein molecules whose physical properties are similar to the physical properties of said antiligand.

23. The method of claim 21, wherein at least one of (a) the bulk conductance of said test volume, and (b) the bulk conductance of a second control volume is further compared with the bulk conductance of said control volume, and wherein said fluid sample contains a known concentration of a control ligand, and control antiligand which interacts with said control ligand is localized in at least one predetermined region of said second control volume.

24. The method claim 1, including the step of forming a complex between a ligand which interacts with said antiligand and an amplifying substance.

25. The method of claim 24, wherein said complex is preformed and added to said fluid sample, said ligand component of said complex being present in a known amount.

26. The method of claim 24, wherein said complex is preformed and prebound to said antiligand in said predetermined region.

27. The method of claim 24, wherein said complex is preformed and compartmentalized in at least one region which is adjacent said predetermined region containing said localized antiligand, said compartment being at least partially within said test volume.

28. The method of claim 24, wherein said complex is formed in said fluid sample, said ligand component of said complex being derived from the ligand present in said fluid sample.

29. The method of claim 28, including the step of adding a known amount of ligand which interacts with said antiligand to said fluid sample containing said complex therein.

30. The method of claim 24, wherein said amplifying substance is a particle selected from the group consisting of antiligand which interacts with said ligand, antiligand which interacts with said ligand bound to a second amplifying substance, macromolecules, cells, small molecules, molecular complexes, latex beads, lipid vesicles, non-conducting polymer beads, other non-conducting particles, magnetic particles, and mixtures thereof.

31. The method of claim 30, wherein said particle is antiligand which interacts with said ligand bound to said second amplifying substance.

32. The method of claim 31, wherein said second amplifying substance can be further reacted to effect a change in the bulk conductance of said test volume.

33. The method of claim 32, wherein said further reaction comprises generation of a gas.

42. The method of claim 11, including the step of forming a complex between a ligand which interacts with said antiligand and an amplifying substance.

43. The method of claim 42, wherein said complex is preformed and compartmentalized in at least one region which is adjacent said predetermined region containing said localized antiligand, said compartment being at least partially within said test volume.

34. A method for determining the presence of a ligand in a fluid sample comprising:

(a) localizing ligand in at least one predetermined region, said predetermined region being at least partially contained within a test volume;

(b) exposing said predetermined region to said fluid sample and to an antiligand which interacts both with said ligand in said fluid sample and said localized ligand; and

(c) measuring the bulk conductance of said test volume to determine the occurrence of ligand-antiligand interaction by detecting changes in the bulk conductance of said test volume.

35. The method of claim 34, wherein said changes in bulk conductance are determined by comparing the bulk conductance of said test volume with the bulk conductance of at least one control volume.

36. The method of claim 34, wherein said localization of said localized ligand comprises confining said ligand within the boudaries of a membrane, said membrane being permeable to at least said antiligand and said ligand present in said fluid sample.

37. The method of claim 34, including the step of forming a complex between antiligand which interacts with said ligand and an amplifying substance.

38. The method of claim 34, including the step of forming a complex between a ligand which interacts with said antiligand and an amplifying substance.

39. The method of claim 34, wherein localization of said localized ligand comprises immobilization on a matrix.

40. The method of claim 39, wherein said matrix is contacted with a flowing stream of said fluid sample.

41. A method for determining the presence of a ligand in a fluid sample comprising:

(a) localizing antiligand which interacts with said ligand in at least one predetermined region, said predetermined region being separate from a test volume;

(b) exposing said predetermined region to said fluid sample; and

(c) measuring the bulk conductance of said test volume to determine the occurrence of ligand-antiligand interaction in said predetermined region by detecting changes in the bulk conductance of said test volume due to ligand-antiligand interaction in said predetermined region.

44. A sensor for determining the presence of a ligand in a fluid sample, said sensor comprising:

(a) means for localizing (i) antiligand which interacts with said ligand or (ii) ligand which interacts with an antiligand, which antiligand also interacts with said ligand in said fluid sample, said localizing means selected from the group consisting of (a) a semipermeable membrane which is permeable at least to said ligand or (b) a matrix material selected from the group consisting of gel beads, gel layers, glass beads, polymeric beads, microporous membranes, porous paper, and mixtures thereof; and

(b) means for measuring the bulk conductance of a test volume which at least partially includes said localizing means.

45. An apparatus for determining the presence of a ligand in a fluid sample, said apparatus comprising:

(a) in at least one predetermined region of said apparatus, means for localizing (i) antiligand which interacts with said ligand or (ii) ligand which interacts with an antiligand, which antiligand also interacts with said ligand in said fluid sample, said localizing means selected from the group consisting of (a) a semipermeable membrane which is permeable at least to said ligand or (b) a matrix material selected from the group consisting of gel beads, gel layers, glass beads, polymeric beads, microporous membranes, porous paper, and mixtures thereof;

(b) means for contacting said fluid sample with said localizing means; and

(c) means for measuring the bulk conductance of a test volume which at least partially contains said predetermined region.

46. The apparatus of claim 45, wherein said region comprises at least one test region for determining the presence of said ligand and at least one control region to provide a comparative basis for making said measurement.

47. The apparatus of claim 45, wherein said test volume essentially entirely includes said localizing means.

48. The apparatus of claim 45, wherein said contacting means comprise a structure having:

(a) an inlet channel for bringing said fluid sample to said localizing means; and

(b) an outlet channel for removing said fluid sample from said localizing means.

49. The apparatus of claim 48, wherein said structure comprises a non-conductive material.

50. The apparatus of claim 45, wherein said non-conductive material is selected from the group consisting of plastic, ceramic, glass, quartz, and mixtures thereof.

51. The apparatus of claim 48, wherein said structure comprises at least three component parts, said first component part comprising said inlet channel, said second component part comprising said outlet channel, and said third component part comprising said localizing means, said first and second component parts being fastened in a sandwiched fashion about said third component part, said third component part being insertable between said first and second component parts.

52. The apparatus of claim 51, further comprising a fluid bath, wherein at least said inlet and outlet channels are submerged in said fluid bath.

53. The apparatus of claim 45, wherein said means for measuring the bulk conductance comprises a plurality of spaced-apart electrodes.

54. The apparatus of claim 53, wherein said apparatus additionally includes a current-modulating material adjacent to said localizing means.

55. The apparatus of claim 53, wherein said localizing means additionally comprises a current modulating material.

56. The apparatus of claim 53, wherein said plurality of electrodes are in contact with an electrolyte.

57. The apparatus of claim 56, wherein said plurality of electrodes comprises two electrodes.

58. The apparatus of claim 57, wherein said plurality of electrodes includes auxiliary electrodes.

59. The apparatus of claim 58, wherein said auxiliary electrodes comprise guard electrodes.

60. The apparatus of claim 56, wherein said plurality of electrodes comprises at least four electrodes.

61. The apparatus of claim 60, wherein two of said electrodes provide a current through said test volume and two measure the drop in voltage across said test volume.

62. The apparatus of claim 61, wherein said plurality of electrodes also includes auxiliary electrodes.

63. The apparatus of claim 62, wherein said auxiliary electrodes comprise guard electrodes.

64. The apparatus of claim 61, wherein each of said current electrodes and each of said voltage electrodes is placed on opposite sides of said localizing means.

65. The apparatus of claim 64, wherein said localizing means essentially entirely includes said test volume.

66. The apparatus of claim 61, wherein said current electrodes are recessed from said test volume.

67. The apparatus of claim 66, wherein said recession comprises placing said current electrodes in chambers, said chambers being in electrical contact with said test volume via conducting channels.

68. The apparatus of claim 67, wherein said conducting channels additionally contain a matrix which retards bubble formation and convection.

69. The apparatus of claim 61, wherein said current electrodes and said voltage electrodes are on the same side of said localizing means.

70. The apparatus of claim 69, wherein said current electrodes and said voltage electrodes lie in the same plane.

71. The apparatus of claim 70, wherein said voltage electrodes are recessed from said current flow.

72. The apparatus of claim 70, wherein said current electrodes are recessed from said test volume.

73. The apparatus of claim 70, wherein said apparatus additionally includes a current-modulating material adjacent to said localizing means.

74. The apparatus of claim 61, wherein said voltage electrodes are recessed from current flow.

75. The apparatus of claim 74, wherein said recession comprises placing said voltage electrodes in chambers, said chambers being in electrical contact with said test volume via conducting channels.

76. The apparatus of claim 75, wherein the width of the opening of said conducting channels adjacent to said test volume ranges from about 25 um to 100 um, and said openings are from about 40 um to 200 um apart with respect to each other.

77. The apparatus of claim 75, wherein said conducting channels additionally contain a matrix which retards bubble formation and convection.

78. The apparatus of claim 77, wherein said localizing means also comprises said matrix contained in said conducting channels.

79. The apparatus of claim 75, wherein the width of the opening of said conducting channels ranges from about 10 um to about 1 mm, and said openings are from about 10 um to about 1 mm apart with respect to each other.

80. The apparatus of claim 79, wherein said test volume ranges up to about 1 ul.

81. The apparatus of claim 79, wherein said test volume is less than about 0.1 ul.

82. The apparatus of claim 79, wherein the thickness of said test volume ranges up to about 1 mm.

83. The apparatus of claim 79, wherein the thickness of said test volume is less than about 0.1 mm.

84. The apparatus of claim 79, wherein the volume of said predetermined region is less than about 0.1 ul.

85. The apparatus of claim 79, wherein the thickness of said predetermined region is less than about 0.1 mm.